ArriVent BioPharma Inc —— 财务报表 (NASDAQ:AVBP) | MetaTrader

展开完整图表

新闻

Are Medical Stocks Lagging AstraZeneca (AZN) This Year?

Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?

ArriVent BioPharma: Phase 3 Delay May Signal Stronger Outcomes For Firmonertinib (NASDAQ:AVBP)

BTIG首次覆盖ArriVent股票,基于肿瘤学管线给予买入评级

BTIG initiates ArriVent stock coverage with buy rating on oncology pipeline

Wall Street Analysts See a 70.37% Upside in ArriVent BioPharma, Inc. (AVBP): Can the Stock Really Move This High?

Is ArriVent BioPharma, Inc. (AVBP) Stock Outpacing Its Medical Peers This Year?

Cantor Fitzgerald重申ArriVent股票评级为"增持"

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer维持ArriVent BioPharma股票"跑赢大盘"评级

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy